Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
14,65 USD | +3,31% | -0,14% | -9,18% |
Attività
Numero di dipendenti: 355
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Switch Control Kinase Inhibitor Platform
100,0
%
| 126 | 100,0 % | 159 | 100,0 % | +26,75% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
76,4
%
| 97 | 77,5 % | 122 | 76,4 % | +25,03% |
Rest of World
12,3
%
| 14 | 11,1 % | 20 | 12,3 % | +39,91% |
Germany
11,3
%
| 14 | 11,4 % | 18 | 11,3 % | +25,58% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17/05/18 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 01/02/15 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Chief Tech/Sci/R&D Officer | - | 01/01/17 | |
Dashyant Dhanak
CTO | Chief Tech/Sci/R&D Officer | 63 | 05/09/23 |
Matthew Sherman
CTO | Chief Tech/Sci/R&D Officer | 68 | 02/10/19 |
Lisa Amaya Price
HRO | Human Resources Officer | - | 01/01/22 |
Kelley Dealhoy
PRN | Corporate Officer/Principal | - | 16/06/22 |
Jama Pitman
PRN | Corporate Officer/Principal | 45 | 01/01/15 |
Daniel Martin
PRN | Corporate Officer/Principal | 49 | 18/09/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 01/09/16 |
Edward Benz
BRD | Director/Board Member | 78 | 01/07/19 |
Ron Squarer
CHM | Chairman | 57 | 04/12/19 |
John R. Martin
BRD | Director/Board Member | 63 | 01/02/15 |
James Bristol
BRD | Director/Board Member | 77 | 01/08/07 |
Susan Kelley
BRD | Director/Board Member | 69 | 08/07/19 |
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17/05/18 |
Dennis Walsh
BRD | Director/Board Member | 56 | 01/02/15 |
Director/Board Member | 66 | 01/11/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 82 225 972 | 57 541 331 ( 69,98 %) | 0 | 69,98 % |
Coordinate società
Settore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-9,18% | 1,2 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione DCPH
- Società Deciphera Pharmaceuticals, Inc.